Literature DB >> 21913281

Drug certainty-response in interview-based studies.

Wai-Ping Yau1, Kueiyu Joshua Lin, Martha M Werler, Carol Louik, Allen A Mitchell, Sonia Hernández-Díaz.   

Abstract

PURPOSE: Imperfect recall of exposure timing challenges the ascertainment of medications in interview-based studies.
METHODS: We propose an algorithm to classify medication exposure, taking into account recall certainty. The availability of medication use details, including duration of use, start and stop dates, and maternal estimates of how certain they were about these dates, allowed classification of subjects as either likely or possibly exposed in the first trimester of pregnancy. We applied the algorithm to study an association between prenatal tetracycline exposure and risk of congenital heart defects previously reported by the National Birth Defects Prevention Study, using 1993-2008 data from 11,517 subjects in the Slone Epidemiology Center Birth Defects Study.
RESULTS: Among women exposed to tetracyclines during pregnancy (n = 58), 50% and 19% were likely and possibly exposed, respectively, in the first trimester, and 31% were exposed outside the first trimester. Compared with non-use during pregnancy, the crude OR for exposure outside the first trimester was 1.0 (95%CI 0.4-2.5), and that for exposed (likely or possibly, combined) in the first trimester was 1.7 (95%CI 0.9-3.2); however, the ORs based on the algorithms were 0.9 (95%CI 0.3-3.0) for possibly exposed and 2.2 (95%CI 1.0-4.6) for likely exposed.
CONCLUSIONS: A "certainty-response" (stronger association with higher level of certainty) was found within exposures in the window of etiological interest. Algorithms for exposure classification that incorporate recall certainty may be useful in interview-based studies.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913281      PMCID: PMC3222943          DOI: 10.1002/pds.2234

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  2 in total

1.  Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.

Authors:  Krista S Crider; Mario A Cleves; Jennita Reefhuis; Robert J Berry; Charlotte A Hobbs; Dale J Hu
Journal:  Arch Pediatr Adolesc Med       Date:  2009-11

2.  Effect of questionnaire design on recall of drug exposure in pregnancy.

Authors:  A A Mitchell; L B Cottler; S Shapiro
Journal:  Am J Epidemiol       Date:  1986-04       Impact factor: 4.897

  2 in total
  7 in total

1.  Assessment of antihistamine use in early pregnancy and birth defects.

Authors:  Qian Li; Allen A Mitchell; Martha M Werler; Wai-Ping Yau; Sonia Hernández-Díaz
Journal:  J Allergy Clin Immunol Pract       Date:  2013-09-12

2.  Use of decongestants during pregnancy and the risk of birth defects.

Authors:  Wai-Ping Yau; Allen A Mitchell; Kueiyu Joshua Lin; Martha M Werler; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2013-07-03       Impact factor: 4.897

3.  Maternal exposure to amoxicillin and the risk of oral clefts.

Authors:  Kueiyu Joshua Lin; Allen A Mitchell; Wai-Ping Yau; Carol Louik; Sonia Hernández-Díaz
Journal:  Epidemiology       Date:  2012-09       Impact factor: 4.822

4.  Predictors of recall certainty of dates of analgesic medication use in pregnancy.

Authors:  Rose G Radin; Allen A Mitchell; Martha M Werler
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-06-04       Impact factor: 2.890

5.  Safety of macrolides during pregnancy.

Authors:  Kueiyu Joshua Lin; Allen A Mitchell; Wai-Ping Yau; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2012-12-16       Impact factor: 8.661

6.  Impact of time to maternal interview on interview responses in the National Birth Defects Prevention Study.

Authors:  Sarah C Tinker; Cassandra Gibbs; Matthew J Strickland; Owen J Devine; Krista S Crider; Martha M Werler; Marlene T Anderka; Jennita Reefhuis
Journal:  Am J Epidemiol       Date:  2013-05-03       Impact factor: 4.897

Review 7.  Antihistamines and birth defects: a systematic review of the literature.

Authors:  Suzanne M Gilboa; Elizabeth C Ailes; Ramona P Rai; Jaynia A Anderson; Margaret A Honein
Journal:  Expert Opin Drug Saf       Date:  2014-10-11       Impact factor: 4.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.